Infectious Diseases
Research Labs

The Andrews Lab

Control of Infectious Diseases in Resource-Limited Settings

Our laboratory aims to develop innovative approaches to the control of infectious diseases in resource-limited settings. Drawing upon the fields of epidemiology, microbiology and engineering, we strive to find solutions to extend the technologies that underlie diagnosis and treatment of infectious diseases to "last-mile" communities.


The Blish Lab

Defining Natural Immunity in Viral Disease

The Blish laboratory is in the Department of Medicine, Division of Infectious Diseases and Geographic Medicine and in the interdisciplinary Stanford Immunology program. Our goal is to develop new methods to prevent and control infectious diseases through better understanding of human immunology. We have several major areas of ongoing investigation.


The Bollyky Lab

Immune Responses in Injured and Infected Tissues 

Our lab studies how immune responses are regulated within injured and infected tissues. We work at the intersection of immunology, structural biology, bioengineering, and microbiology. Our goals are to understand the factors that drive chronic inflammation and to develop novel therapeutics to promote wound healing and immune tolerance.


The Einav Lab

Understanding Virus-Host Protein Interactions

The goals of our lab are to better understand virus-host protein interactions, identify host proteins or pathways required by multiple viruses, and translate this knowledge into the development of novel, broad-spectrum, host-centered antiviral approaches with a high genetic barrier for resistance.


Jagannathan Lab

Translational Immunology Focused on Malaria-Specific Immune Responses

The goals of this laboratory are to further our understanding of the correlates and mechanisms of clinical immunity to malaria through field-based studies, and to better understand the immunologic consequences of malaria control interventions.

These studies bridge immune profiling techniques including multiparameter flow cytometry, transcriptomics, epigenetics, and multiplex antibody profiling to epidemiologic studies of antimalarial immunity in children.

The Parsonnet Lab

Investigating Chronic Disease-Infection Links

The laboratory's primary research interest is investigating the role of infectious agents in chronic diseases. Much of this work has revolved around Helicobacter pylori infection as a cause of adenocarcinomas and lymphomas of the stomach. 


The Relman Lab

Host-Microbe Interactions & Human Microbial Ecology

David Relman's investigative program falls within the general themes of host-pathogen interactions and human microbial ecology, and is divided into two research areas:

  1. Ecology of microbial communities indigenous to humans and other mammalian hosts
  2. Genome-wide host response patterns in systemic infectious disease

The Shafer Lab

Virus Evolution focused on HIV Therapy and Drug Resistance

My group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. These three disciplines – epidemiology, clinical management, and basic science – reflect the interdisciplinary nature of antiviral drug resistance research and represent the range of our group’s activities. 


The Singh Lab

Identifying Virulence Mechanisms Parasites Develop to Cause Disease

Our lab studies the molecular basis of pathogenesis of two medically important parasites, Toxoplasma gondii and Entamoeba histolytica. The work is aimed at understanding the virulence determinant that each parasite uses in causing disease, specifically how T. gondii evades the human immune response by converting to a dormant bradyzoite stage and how E. histolyticacauses invasive colonic and hepatic disease.


The Wang Lab

Human Immune Functions & Susceptibility to Diseases

Taia Wang’s laboratory studies mechanisms underlying the heterogeneity in human immune function during vaccination and viral infection.  We are particularly interested in antibody-mediated immunity and determinants of susceptibility to antibody-mediated diseases.